Skip to main content

Table 3 Kruskal-Wallis H Test analysis for Hp eradication rates

From: Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial

 

Group

Eradication rate

P

H(K)

ITT

V1

38/45 (84.4%)

1.000

0.000

V2

38/45 (84.4%)

V3

38/45 (84.4%)

PP

V1

38/43 (88.4%)

0.757

0.557

V2

38/41 (92.7%)

V3

38/43 (88.4%)

  1. P p-value for Kruskal-Wallis H Test
  2. ITT intention-to-treat, PP per-protocol
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us